Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Molecular profiling in the treatment of colorectal cancer: Focus on regorafenib
Yiyi Yan
, Axel Grothey
Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Molecular profiling in the treatment of colorectal cancer: Focus on regorafenib'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
regorafenib
100%
Colorectal Neoplasms
50%
ramucirumab
20%
Panitumumab
18%
aflibercept
18%
Cetuximab
16%
Biological Therapy
15%
Bevacizumab
14%
Genetic Markers
13%
Vascular Endothelial Growth Factor A
10%
Anti-Idiotypic Antibodies
10%
Therapeutics
10%
Molecular Biology
10%
Biomarkers
8%
Mutation
7%
Survival
7%
Antibodies
7%